GERALD M. ROSEN, Ph.D., J.D.; RONALD I. SHORR, B.A.
The judicial and executive branches of the federal government, motivated by emotionalism, political pressure, and a self-appointed need to placate the National Cancer Institute, have reached a decision on laetrile that weakens the legal protection of the general public. Recent approval of clinical trials of laetrile by the Food and Drug Administration was not consistent with policies adopted earlier, nor was it warranted by federal court decisions.
Learn more about subscription options.
Register Now for a free account.
ROSEN GM, SHORR RI. Laetrile: A Survey of Judicial and Administrative Activity. Ann Intern Med. 1981;94:530–533. doi: 10.7326/0003-4819-94-4-530
Download citation file:
Published: Ann Intern Med. 1981;94(4_Part_1):530-533.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only